Buyback

Transaction in own shares

Thursday, May 6, 2021 - 6:03pm

b'Dissemination of a Regulatory Announcement, transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\nLONDON, 06 May 2021: Arix Bioscience plc ("Arix" or "the Company") (LSE:ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that it purchased the following number of its ordinary shares of 0.001 pence each on the London Stock Exchange from Jefferies International Limited as part of a buyback programme announced on 22 March 2021.\nArix intends to retain the purchased shares in treasury.\nFollowing settlement of the above purchase, Arix will have 133,075,800 ordinary shares of 0.001 pence each in issue (excluding 2,533,853 ordinary shares of 0.001 pence each held in treasury).

Key Points: 
  • b'Dissemination of a Regulatory Announcement, transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\nLONDON, 06 May 2021: Arix Bioscience plc ("Arix" or "the Company") (LSE:ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that it purchased the following number of its ordinary shares of 0.001 pence each on the London Stock Exchange from Jefferies International Limited as part of a buyback programme announced on 22 March 2021.\nArix intends to retain the purchased shares in treasury.\nFollowing settlement of the above purchase, Arix will have 133,075,800 ordinary shares of 0.001 pence each in issue (excluding 2,533,853 ordinary shares of 0.001 pence each held in treasury).
  • This number represents the total voting rights in Arix and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority\'s Disclosure and Transparency Rules.\nIn accordance with Article 5(1)(b) of Regulation (EU) No.
  • 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), the schedule below contains detailed information of the individual trades made by Jefferies International Limited as part of the buyback programme.\nFor more information on Arix, please contact:\n'

DGAP-News: Energiekontor decides to cancel shares

Thursday, May 6, 2021 - 4:06pm

On the basis of this authorisation, the Company had acquired 377,144 no-par value bearer shares of the Company on the stock exchange by 8 May 2020.

Key Points: 
  • On the basis of this authorisation, the Company had acquired 377,144 no-par value bearer shares of the Company on the stock exchange by 8 May 2020.
  • Accordingly, 27,144 no-par bearer shares remained in Energiekontor's possession from this share buyback.\nBy resolution of the ordinary general meetings of Energiekontor AG on 20 May 2020, the Executive Board was authorised pursuant to Section 71 (1) No.
  • 8 of the German Stock Corporation Act (AktG) to acquire treasury shares of up to 10 percent of the share capital.
  • In addition, Energiekontor operates wind and solar farms with a nominal output of almost 280 megawatts in its own portfolio.

Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM

Thursday, May 6, 2021 - 1:09pm

b"In the last 24 months prior to May 6th, 2021\nCovering the period starting the day following the assement of the previous program was established and ending on May 5th,2021.

Key Points: 
  • b"In the last 24 months prior to May 6th, 2021\nCovering the period starting the day following the assement of the previous program was established and ending on May 5th,2021.
  • Transaction made as part of block transactions or liquidity contract.\nNumber of tresury shares owned directly and indireclty : 465,132 representing 2,14 % of the company capital.\nMaximum proportion of the share capital authorised for buyback : 10 % currently equivalent to 2,171,302 shares.
  • Given the number of shares already held and amounting to 465,132 (2.14 % of the share capital), the maximum number of additional shares that can be bought will be 1,706,170 shares (7,86 % of the share capital) unless the Company sells or cancels the shares already held.\nStimulate the market or the liquidity of the Company's shares through an investment service provider under a liquidity agreement that complies with the AMAFI Ethics Charter recognized by the AMF,\nAcquire shares to be held and subsequently delivered in payment or exchanged as part of corporate acquisition transactions,\nAward or transfer stock to employees and/or corporate officers ( on the terms and in the manner provided for by law) in particular as part of a stock option plan, a bonus share award plan or a company savings plan,\nAward stock by the delivery of shares when exercising the rights attached to securities giving the right via redemption, conversion, exchange or presentation of a warrant, or in any other way, to an allocation of the Company's stock,\nPotentially cancel the shares acquired, under the conditions of the authorization granted by the Shareholder's Meeting.\nProgram duration : 18 months after Shareholders'Meeting held on May 6th 2021, so up to November the 6th , 2022.\nThis press release is available on the website: www.kaufmanbroad.fr\n"

Transaction in own shares

Wednesday, May 5, 2021 - 5:20pm

b'Dissemination of a Regulatory Announcement, transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\nLONDON, 05 May 2021: Arix Bioscience plc ("Arix" or "the Company") (LSE:ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that it purchased the following number of its ordinary shares of 0.001 pence each on the London Stock Exchange from Jefferies International Limited as part of a buyback programme announced on 22 March 2021.\nArix intends to retain the purchased shares in treasury.\nFollowing settlement of the above purchase, Arix will have 133,100,800 ordinary shares of 0.001 pence each in issue (excluding 2,508,853 ordinary shares of 0.001 pence each held in treasury).

Key Points: 
  • b'Dissemination of a Regulatory Announcement, transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\nLONDON, 05 May 2021: Arix Bioscience plc ("Arix" or "the Company") (LSE:ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that it purchased the following number of its ordinary shares of 0.001 pence each on the London Stock Exchange from Jefferies International Limited as part of a buyback programme announced on 22 March 2021.\nArix intends to retain the purchased shares in treasury.\nFollowing settlement of the above purchase, Arix will have 133,100,800 ordinary shares of 0.001 pence each in issue (excluding 2,508,853 ordinary shares of 0.001 pence each held in treasury).
  • This number represents the total voting rights in Arix and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority\'s Disclosure and Transparency Rules.\nIn accordance with Article 5(1)(b) of Regulation (EU) No.
  • 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), the schedule below contains detailed information of the individual trades made by Jefferies International Limited as part of the buyback programme.\nFor more information on Arix, please contact:\n'

Transaction in own shares

Tuesday, May 4, 2021 - 6:27pm

b'Dissemination of a Regulatory Announcement, transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\nLONDON, 04 May 2021: Arix Bioscience plc ("Arix" or "the Company") (LSE:ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that it purchased the following number of its ordinary shares of 0.001 pence each on the London Stock Exchange from Jefferies International Limited as part of a buyback programme announced on 22 March 2021.\nArix intends to retain the purchased shares in treasury.\nFollowing settlement of the above purchase, Arix will have 133,200,800 ordinary shares of 0.001 pence each in issue (excluding 2,408,853 ordinary shares of 0.001 pence each held in treasury).

Key Points: 
  • b'Dissemination of a Regulatory Announcement, transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\nLONDON, 04 May 2021: Arix Bioscience plc ("Arix" or "the Company") (LSE:ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that it purchased the following number of its ordinary shares of 0.001 pence each on the London Stock Exchange from Jefferies International Limited as part of a buyback programme announced on 22 March 2021.\nArix intends to retain the purchased shares in treasury.\nFollowing settlement of the above purchase, Arix will have 133,200,800 ordinary shares of 0.001 pence each in issue (excluding 2,408,853 ordinary shares of 0.001 pence each held in treasury).
  • This number represents the total voting rights in Arix and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority\'s Disclosure and Transparency Rules.\nIn accordance with Article 5(1)(b) of Regulation (EU) No.
  • 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), the schedule below contains detailed information of the individual trades made by Jefferies International Limited as part of the buyback programme.\nFor more information on Arix, please contact:\n'

Ahold Delhaize share buyback update

Tuesday, May 4, 2021 - 7:00am

b'Zaandam, the Netherlands, May 4, 2021 \xe2\x80\x93 Ahold Delhaize has repurchased 1,103,694 of Ahold Delhaize common shares in the period from April 26, 2021 up to and including April 30, 2021.

Key Points: 
  • b'Zaandam, the Netherlands, May 4, 2021 \xe2\x80\x93 Ahold Delhaize has repurchased 1,103,694 of Ahold Delhaize common shares in the period from April 26, 2021 up to and including April 30, 2021.
  • The shares were repurchased at an average price of \xe2\x82\xac 22.62 per share for a total consideration of \xe2\x82\xac 25 million.
  • These repurchases were made as part of the \xe2\x82\xac1 billion share buyback program announced on November 4, 2020.\nThe total number of shares repurchased under this program to date is 18,870,492 common shares for a total consideration of \xe2\x82\xac 434.6 million.\nThis press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation that contains technical standards for buyback programs.\n'

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

Monday, May 3, 2021 - 7:18pm

b'Since the announcement of the Fourth Tranche of the buyback program dated March 11, 2021 till April 30, 2021, the total invested consideration has been:\n\xe2\x80\xa2\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0 Euro 34,593,609.69 for No.

Key Points: 
  • b'Since the announcement of the Fourth Tranche of the buyback program dated March 11, 2021 till April 30, 2021, the total invested consideration has been:\n\xe2\x80\xa2\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0 Euro 34,593,609.69 for No.
  • 199,037 common shares purchased on the MTA.\n\xe2\x80\xa2\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0 USD 2,829,445.63 (Euro 2,375,650.39*) for No.
  • 13,558 common shares purchased on the NYSE\nAs of April 30, 2021, the Company held in treasury No.
  • 9,125,106 common shares equal to 3.55% of the total issued share capital including the common shares and the special voting shares, net of shares assigned under the Company\xe2\x80\x99s equity incentive plan.\nSince January 1, 2019 until April 30, 2021, the Company has purchased a total of 3,939,780 own common shares on MTA and NYSE for a total consideration of Euro 540,391,493.24.\nA comprehensive overview of the transactions carried out under the buyback program, as well as the details of the above transactions, are available on Ferrari\xe2\x80\x99s corporate website under the Buyback Programs section ( http://corporate.ferrari.com/en/investors/stock-and-shareholder-corner/b... ).\n'

Buybacks of shares in Alfa Laval during week 17 2021

Monday, May 3, 2021 - 2:46pm

b'LUND, Sweden, May 3, 2021 /PRNewswire/ --During the period April 28 - April 30, 2021, Alfa Laval AB (publ) (LEI code: 549300UCKT2UK88AG251) has repurchased in total 82,500 own shares (ISIN: SE0000695876) as part of the share buyback program initiated by the Board of Directors in order to secure optimized capital structure.\nThe share buybacks form part of the SEK 2 billion share buyback program, which Alfa Laval announced on April 27, 2021.

Key Points: 
  • b'LUND, Sweden, May 3, 2021 /PRNewswire/ --During the period April 28 - April 30, 2021, Alfa Laval AB (publ) (LEI code: 549300UCKT2UK88AG251) has repurchased in total 82,500 own shares (ISIN: SE0000695876) as part of the share buyback program initiated by the Board of Directors in order to secure optimized capital structure.\nThe share buybacks form part of the SEK 2 billion share buyback program, which Alfa Laval announced on April 27, 2021.
  • The share buy-back program, which runs between April 28, 2021 and April 25, 2022, is being carried out in accordance with the EU Market Abuse Regulation (MAR) and the Commission Delegated Regulation 2016/1052 (the so-called Safe Harbour Regulation).\nShares in Alfa Laval have been repurchased as follows:\n'

ASML reports transactions under its current share buyback program

Monday, May 3, 2021 - 1:00pm

b'ASML\xe2\x80\x99s current share buyback program was announced on 22 January 2020, and details are available on our website at https://www.asml.com/ en/news/share-buyback\nThis regular update of the transactions conducted under the buyback program is to be made public under the Market Abuse Regulation (Nr.

Key Points: 
  • b'ASML\xe2\x80\x99s current share buyback program was announced on 22 January 2020, and details are available on our website at https://www.asml.com/ en/news/share-buyback\nThis regular update of the transactions conducted under the buyback program is to be made public under the Market Abuse Regulation (Nr.
  • 596/2014).\n'

DGAP-News: AlzChem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 7th Interim report

Monday, May 3, 2021 - 9:01am

b'The issuer is solely responsible for the content of this announcement.\nIn the period from April 26, 2021 up to and including April 30, 2021, a total of 3.091 shares of AlzChem Group AG were acquired as part of the share buyback program announced on February 2, 2021.

Key Points: 
  • b'The issuer is solely responsible for the content of this announcement.\nIn the period from April 26, 2021 up to and including April 30, 2021, a total of 3.091 shares of AlzChem Group AG were acquired as part of the share buyback program announced on February 2, 2021.
  • The total number of shares acquired to date as part of this buyback amounts to 17.932.
  • The acquisition was carried out by ODDO BHF Aktiengesellschaft, Frankfurt am Main/Germany via the stock exchange (XETRA) on behalf of AlzChem Group AG.\nThe total number of repurchased shares, the weighted average price and the aggregated volume per day were as follows:\n'